Mamawi, Hazel .

HRN: 24-23-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2024
CEFUROXIME 500MG (TAB)
11/25/2024
12/02/2024
ORAL
500mg
BID
S/P NSD With RMLE
Waiting Final Action 
11/29/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/29/2024
12/04/2024
IV
900mg
Q8 Hrs
Endometritis
Waiting Final Action 
11/29/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
11/29/2024
12/06/2024
IV
300mg
OD
Endometritis
Waiting Final Action 
12/03/2024
CLINDAMYCIN 300MG (CAP)
12/03/2024
12/09/2024
PO
300mg
Q8
T/c Endometritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: